Patents for C12P 17 - Preparation of heterocyclic carbon compounds with only o, n, s, se, or te as ring hetero atoms (13,366)
03/2005
03/03/2005DE10335447A1 New amino-oxidase from Streptomyces thioluteus, useful in synthesis of the polyketide antibiotic aureothin
03/02/2005EP1509599A1 Aldehyde dehydrogenase
03/02/2005EP0783582B1 PROCESS OF PRODUCING $g(b)-LACTAM ANTIBIOTICS APPLYING MICROORGANISMS WITH INCREASED LIGASE ACTIVITY
03/02/2005CN1587383A New method for modifying clavulanic acid producing bacteria and high yield clavulanic acid producing bacteria
03/02/2005CN1191372C Resolution of trans-2-(alkoxycarbonylethyl)-laitams useful in synthesis of 1-(4-fluorphenyl)-3(R)-[3(S)-hydroxy-3-(flurophenyl)-propyl)]-4(S)-(4-hydroxyphenyl)-2-azetidinone
03/02/2005CN1191367C Process for purifying swainsonine by biofermentation
03/02/2005CN1191366C Process for extracting taxol from taxus cuspidata
02/2005
02/24/2005WO2005017172A1 Microbial production of l-ascorbic acid
02/24/2005WO2005017159A2 Microbial production of l-ascorbic acid
02/24/2005WO2005017099A2 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
02/24/2005WO2005016851A1 Recombined molecules and preparation thereof
02/24/2005WO2004050684A3 Methods for improving secondary metabolite production in fungi
02/24/2005US20050043297 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
02/24/2005US20050042726 Nucleotide sequences coding functional fragment of viomycin gene cluster for use in treatment of tuberculosis
02/24/2005US20050042648 Vitro sorting method
02/24/2005CA2852159A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
02/24/2005CA2526595A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
02/23/2005EP1407036A4 Flavonoid concentrates
02/23/2005CN1585824A Enzymatic process for the manufacture of L-ascorbic acid and D-erythorbic acid
02/23/2005CN1584039A Preparation of scutellarin from scullcaposide glucuronyl by enzyme hydrolysis
02/23/2005CN1584038A Biological conversion and extraction and purification of soy bean isoflavone
02/23/2005CN1584016A Amycolatosis and biological conversion of lovastatin into wuxistatin thereby
02/23/2005CN1190497C Preparation technology of geldananycin
02/22/2005US6858591 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives
02/22/2005US6858416 Human desaturase gene and uses thereof
02/22/2005US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants
02/22/2005US6858404 Genes for the biosynthesis of epothilones
02/22/2005CA2194043C Compound gex1
02/17/2005WO2005014844A1 L-gulose dependent vitamin c synthesis
02/17/2005WO2005014839A2 Monatin tabletop sweetener compositions and methods of making same
02/17/2005WO2005014834A1 Fatty acid biosynthesis 3
02/17/2005WO2004101803A3 Process for producing anticancer agent ll-d45042
02/17/2005WO2004058976A3 Borrelidin-producing polyketide synthase and its use
02/17/2005WO2002101013A3 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates
02/17/2005US20050038255 Stereoselective preparation of cyclic l-amino acids
02/17/2005US20050038254 Efficient incubation preparation of such as terfenadine carboxylic acid metabolite
02/17/2005US20050038090 cytotoxic agents; made by fermentation of Streptomyces sparsogenes
02/17/2005US20050038086 Epothilone derivatives and methods for making and using the same
02/17/2005US20050037355 Measuring intracellular adenosine triphosphate and/or gene expression in transgenic cell via monitoring luciferin bioluminescent signals; genetiic engineering and reporter molecules
02/17/2005CA2532683A1 L-gulose dependent vitamin c synthesis
02/16/2005EP1506996A2 Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
02/16/2005EP1506294A1 Hydantoin racemase
02/16/2005CN1580272A Method for producing somatic powder containing lovastatin by liquid submerged fermentation
02/16/2005CN1580271A Method for producing flavone aglycone of ginkgo
02/16/2005CN1189568C Biotransfer process for preparing artemisine compounds
02/15/2005US6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
02/14/2005WO2005024025A1 Polyene polyketides and methods of production
02/10/2005WO2005012498A2 Production of porphyrins
02/10/2005WO2003076581A3 Methods to mediate polyketide synthase module effectiveness
02/10/2005US20050032883 Novel substance fki-1083 and process for producing the same
02/10/2005US20050032184 Disorazole polyketide synthase encoding polynucleotides
02/10/2005US20050032180 from 8-chloro-6 -oxooctanoic acid alkyl esters, using alcohol dehydrogenases or carbonyl reductases in the presence of NADH or NADPH as cofactor; intermediates to alpha-lipoic acid
02/10/2005US20050032176 Modular polyketide synthases with altered activity
02/09/2005EP1504011A1 Microbial n- and o-demethylation of a thebaine derivative
02/09/2005EP1503985A2 Polypeptides and biosynthetic pathways
02/09/2005EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
02/09/2005CN1188521C Coding of gene of protein with synthetic aurone activity
02/09/2005CN1188520C Production of polyketies in plants
02/08/2005US6852715 Formula (1) wherein R1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms; and R2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon
02/08/2005US6852315 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase
02/03/2005WO2005009391A2 Antibiotic compound
02/03/2005WO2004087940A3 PROCESS FOR PRODUCING ENANTIOPURE β-AMINO ACID DERIVATIVES, AND ENANTIOPURE β-AMINO ACID DERIVATIVES
02/03/2005US20050026244 Recombinant narbonolide polyketide synthase
02/03/2005US20050026143 Synthesis of biologically active compounds in cells
02/03/2005CA2532802A1 Antibiotic compound isolated from streptomyces sp
02/03/2005CA2532672A1 Method for producing fats or oils
02/02/2005EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives
02/02/2005EP1501934A1 Manufacture of certain cyclic ester oligomers
02/02/2005EP1501919A1 Soya cell strains with high isoflavone content
02/02/2005EP1280812B1 Cyclipostins, a method for their production and the use of the same
02/02/2005EP0917563B1 Micro-organism which can desulphurise benzothiophenes
02/01/2005US6849281 Food product suitable for reducing low density lipoprotein cholesterol levels
01/2005
01/27/2005US20050019879 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor
01/27/2005US20050019878 Enzymatic process for the manufacture of l-ascorbic acid and d-erythorbic acid
01/26/2005EP1499715A1 Aldehyde dehydrogenase ii
01/26/2005CN1571843A Nitrile hydratase and a method for producing amides
01/26/2005CN1570125A High purity soy bean isoflavone process using supercritical CO#-[2] extraction
01/26/2005CN1186447C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins
01/26/2005CN1186446C Streptomyces avermitilis gene directing ratio of B2:B1 avermectins
01/25/2005US6846654 Catalytic antibodies as chemical sensors
01/20/2005WO2005005618A1 The microorganism and the process for preparation of pravastatin
01/19/2005EP1498489A2 Ascorbic acid production from yeasts
01/19/2005CN1568368A Method for producing L-amino acids
01/19/2005CN1566352A Process for preparing isoflavone aglycon
01/19/2005CN1566328A Microbe and process for preparing pravastatin sodium
01/19/2005CN1566327A Viscosity reduction bacterium for improving petroleum recovery efficiency and its use
01/19/2005CN1566109A Aldose reductase inhibitor, preparation method and use thereof
01/18/2005US6844174 Preparing orlistat precursor from genetically engineered streptomyces; antidiabetic/hypotensive agents; insulin resistance
01/18/2005US6844173 Strain of Streptomyces griseus
01/13/2005WO2005003137A1 Salinosporamides and methods for use thereof
01/13/2005WO2004089958A3 Crystallization and purification of macrolides
01/13/2005WO2004087935A3 Fermentation process for the preparation of pravastatin
01/13/2005WO2004087932A3 Enzymatic resolution of (±) methyl trans-3-phenyl glycidate
01/13/2005US20050010029 Using nucleotide sequence cleavage, rearrangement and ligation to generate novel protein libraries for as tool in evaluating and screening drugs; peptide mimetics; directed evolution of proteins
01/13/2005US20050009869 Quinone-indicator antibiotics, particularly2-heptyl-3-hydroxy-4-quinolone, and analogs; regulating the expression of a bacterial gene; modulating bacteria quorum sensing signaling
01/13/2005US20050009747 High purity lipopeptides
01/13/2005US20050009153 Process of producing glutamate derivatives
01/13/2005CA2530215A1 Salinosporamides and methods for use thereof
01/12/2005EP1496120A2 In vitro sorting method
01/12/2005CN1563400A Method for separating and preparing prodigiosin
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 134